| First Author | Justesen S | Year | 2020 |
| Journal | Biochem J | Volume | 477 |
| Issue | 13 | Pages | 2477-2487 |
| PubMed ID | 32648929 | Mgi Jnum | J:303544 |
| Mgi Id | MGI:6492110 | Doi | 10.1042/BCJ20200220 |
| Citation | Justesen S, et al. (2020) The autocrine role of FGF21 in cultured adipocytes. Biochem J 477(13):2477-2487 |
| abstractText | Exposure to cold alters glucose and lipid metabolism of white and brown adipose tissue via activation of beta-adrenergic receptor (ADRB). Fibroblast growth factor 21 (FGF21) has been shown to be locally released from adipose tissue upon activation of ADRBs and FGF21 increases glucose uptake in adipocytes. Therefore, FGF21 may play an autocrine role in inducing glucose uptake after beta-adrenergic stimulation. To determine the putative autocrine role of FGF21, we stimulated three different types of adipocytes in vitro with Isoprenaline (Iso), an ADRB agonist, in the presence or absence of the FGF receptor (FGFR) inhibitor PD 173074. The three cell lines represent white (3T3-L1), beige (ME3) and brown (WT-1) adipocyte phenotypes, respectively. All three cells systems expressed beta-klotho (KLB) and FGFR1 after differentiation and treatment with recombinant FGF21 increased glucose uptake in 3T3-L1 and WT-1 adipocytes, while no significant effect was observed in ME3. Oppositely, all three cell lines responded to Iso treatment and an increase in glucose uptake and lipolysis were observed. Interestingly, in response to the Iso treatment only the WT-1 adipocytes showed an increase in FGF21 in the medium. This was consistent with the observation that PD 173074 decreased Iso-induced glucose uptake in the WT-1 adipocytes. This suggests that FGF21 plays an autocrine role and increases glucose uptake after beta-adrenergic stimulation of cultured brown WT-1 adipocytes. |
